Exendin-4, glucagon-like peptide-1 receptor agonist, enhances isoflurane-induced preconditioning against myocardial infarction via caveolin-3 expression.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 25912591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3

  2014cited by this paper
• Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.

  2014cited by this paper
• Biophysical and Pharmacological Properties of Glucagon-Like Peptide-1 in Rats Under Isoflurane Anesthesia

  2012cited by this paper
• Role of the O-linked &bgr;-N-acetylglucosamine in the Cardioprotection Induced by Isoflurane

  2011cited by this paper
• Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.

  2010cited by this paper
• Role of Caveolin-3 and Glucose Transporter-4 in Isoflurane-induced Delayed Cardiac Protection

  2010cited by this paper
• Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

  2008cited by this paper
• Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart.

  2008cited by this paper
• Isoflurane Produces Sustained Cardiac Protection after Ischemia–Reperfusion Injury in Mice

  2006cited by this paper
• Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.

  2005cited by this paper
• Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.

  2005cited by this paper
• Circulation and Degradation of GIP and GLP-1

  2004cited by this paper
• Isoflurane-induced preconditioning is attenuated by diabetes.

  2002cited by this paper
• Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

  2002cited by this paper
• Caveolin-3 deficiency causes muscle degeneration in mice.

  2000cited by this paper

• Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists

  2024influential citation
• Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action

  2023cites this paper
• New Therapeutic Options for Type 2 Diabetes Mellitus and Their Impact Against Ischemic Heart Disease

  2022influential citation
• Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists

  2022cites this paper
• Branched-chain amino acids-induced cardiac protection against ischemia/reperfusion injury.

  2020cites this paper
• DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome

  2019cites this paper
• Plasma from Volunteers Breathing Helium Reduces Hypoxia-Induced Cell Damage in Human Endothelial Cells—Mechanisms of Remote Protection Against Hypoxia by Helium

  2019cites this paper
• Helium-mediated regulation of endothelial permeability: involvement of Caveolin-1, VE-Cadherin and Connexin-43

  2019cites this paper
• Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1

  2018cites this paper
• Exendin‐4 inhibits structural remodeling and improves Ca2+ homeostasis in rats with heart failure via the GLP‐1 receptor through the eNOS/cGMP/PKG pathway

  2017cites this paper
• MiR-195 enhances cardiomyocyte apoptosis induced by hypoxia/reoxygenation injury via downregulating c-myb.

  2016cites this paper
• Mechanisms for the cardiovascular effects of glucagon‐like peptide‐1

  2016cites this paper
• Influence and significance of intervening diabetes microRNA expression profile of NOD mice with exendin-4.

  2016cites this paper